Comparative pharmacological evaluation of Ocimum sanctum and imipramine for antidepressant activity

Latin American Journal of Pharmacy

Volumn 30, Issue 3, 2011, Pages 435-439

  Moinuddin, Ghulam ^a   Devi, Kshama ^a   Satish, Hanumantharayashetty ^a   Khajuria, Deepak Kumar ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

Antidepressant activity; Imipramine; Ocimum sanctum

Indexed keywords

HALOPERIDOL; IMIPRAMINE; OCIMUM SANCTUM EXTRACT; PENTOBARBITAL; RESERPINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG USE; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; NONHUMAN; RAT; SLEEP TIME;

EID: 79955099299     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. WHO (1998) Mental and Neurological Disorders. Fact sheet No.25. World Health Organization.
2. Stahl, S.M. (1998) Essential Psychopharmacology: Neuroscientific basis and Practical; Applications. Cambridge Univertsity Press, Cambridge.
3. Richelson, E. (2001) Mayo Clin. Proc. 76: 516-27.
4. World Health Organisation (2001) The World health report 2001: Mental health: new understanding, new hope. Geneva.
5. Tripathi, K.D. (2008) Essentials of medical Pharmacology. 6th ed. Medical Publishers (P) Ltd: New Delhi, India.
6. Hardman, J.G., L.E. Limbird & A.G. Gilman (2007) Goodman & Gilman's; The Pharmacological Basis of Therapeutics. 11th. ed.The Mc-Graw Hill Companies, Inc: New York.
7. Walker, R. & C. Edward (1999) Clinical Pharmacy and Therapeutics II, Churchill Livingstone: Edinburgh, London.
8. Sarandol, A., E. Sarandol, S.S. Eker, S. Erdinc, E. Vatansever & S. Kirli (2007) Human Psychopharmacol. Clin. Exp. 22: 67-73.
9. Ibrahim, E., N. Mustafa, D. Arif, C. Omer, U.A. Cihangir, A. Ayse, O. Ismail & U. Efkan (2007) Neurochem Res. 32: 497-505.
10. Sembulingam, K., P. Sembulingam & A. Namasiyam (1997) Indian J. Physiol. Pharmacol. 41: 139-43.
11. Gupta, S.K., J. Prakash & S. Srivastava (2002) Indian J. Exp. Biol. 40: 765-73.
12. Pemminati, S., V. Nair, P. Dorababu & H.N. Gopalakrishna (2007) Indian J. Pharmacol. 39: 87-9.
13. Hanumanthachar, J. & P. Milind (2006) Indian. J. Exp. Biol. 44: 133-6.
14. Pemminati, S., B. Swati, C. Shreyasi, R. Chandrasekhar, H.N. Gopalakrishna & M.R.S.M. Pai (2010) Drug Invent. Today 2: 115-8.
15. Singh, N., N. Misra, A.K. Srivastava, K.S. Dixit & G.P. Gupta (1991) Indian J. Pharmacol. 23: 137-42.
16. Ravindran, R., R.S. Devi, J. Samson & M. Senthilvelan (2005) J. Pharmacol. Sci. 98: 354-60.
17. Kumar, V., P.N. Singh, A.K. Jaiswal & S.K. Bhattacharya (1999) Indian J. Exp. Biol. 37: 1171-6.
18. Porosolt, R.D., G. Anton, N. Blavet & M. Jalfre (1978) Eur. J. Phamacol. 47: 379-91.
19. Costa, E., S. Garattini & L. Valyelli (1960) Experientia 16: 461-3.
20. Khisti, R.T., S.N. Mandhane & C.T. Chopde (1997) Indian J. Exp. Biol. 35: 1297-301.
21. Das, S. & D. Guha (2007) Indian J. Exp. Biol. 46: 185-90.
22. Liu, J. (1995) J. Ethnopharmacol. 49: 57-68.
23. Sakina, M.R., P.C. Dandiya & M.E. Hamdard (1990) J. Ethnopharmacol. 28: 143-50.
24. Porsolt, R.D. (1981) Behavioural despair, antidepressants: Neurochemical, Behavioural and clinical perspectives (S.J. Enna, J.B. Malick & E. Richelson, eds.), Raven Press, New York pp 121-39.
25. Samberg, P.R. (1980) Nature 284: 472-3.
26. Polydoro, M., N. Schroder, M.N.M. Lima, F. Caldana, D.C. Laranja, E. Bromberg, R. Roesler, J. Quevedo, J.C.F. Moreira & F. Dal-Pizzol (2004) Pharmacol Biochem Behav. 78: 751-66.
27. Schildkraut, J.J. (1965) Am. J. Psychiatry 122: 509-22.
28. Khawaja, X., J.E. Malberg & S. Rosenzweig-Lipson (2005) NeuroRx. 2: 590-611.
29. Richelson, E. (2002) Psychopharmacol. Bull. 36: 133-50.
30. Delini-Stula, A., E. Radeke & H.Van Riezen. (1988) Neuropharmacology 27: 943-7.
31. Singh, N., N. Misra, A.K. Srivastava, K.S. Dixit & G.P. Gupta (1991) Indian J. Pharmacol. 23: 137-42.
32. Nair, A.G.R., R. Gunasegaran & B.S. Joshi (1982) Indian J. Chem. 21(B): 979-80.